|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q59695027
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010730.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q59695027
|
|
024
|
|
|
‡a
0000-0002-3077-9639
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q59695027
|
|
100
|
0 |
|
‡a
Fiona M Russell
‡c
paediatrician, infectious diseases epidemiologist and vaccine researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Fiona M Russell
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's Associations between ethnicity, social contact, and pneumococcal carriage three years post-PCV10 in Fiji
|
|
670
|
|
|
‡a
Author's Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study.
|
|
670
|
|
|
‡a
Author's Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene
|
|
670
|
|
|
‡a
Author's Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children
|
|
670
|
|
|
‡a
Author's Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
|
|
670
|
|
|
‡a
Author's Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis
|
|
670
|
|
|
‡a
Author's Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys
|
|
670
|
|
|
‡a
Author's Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR
|
|
670
|
|
|
‡a
Author's Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes
|
|
670
|
|
|
‡a
Author's No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine
|
|
670
|
|
|
‡a
Author's Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine
|
|
670
|
|
|
‡a
Author's Real-time qPCR improves meningitis pathogen detection in invasive bacterial-vaccine preventable disease surveillance in Fiji
|
|
670
|
|
|
‡a
Author's Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art
|
|
670
|
|
|
‡a
Author's Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children
|
|
670
|
|
|
‡a
Author's Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study
|
|
670
|
|
|
‡a
Author's The cause-specific morbidity and mortality, and referral patterns of all neonates admitted to a tertiary referral hospital in the northern provinces of Vietnam over a one year period.
|
|
670
|
|
|
‡a
Author's The Challenges of Using Oropharyngeal Samples To Measure Pneumococcal Carriage in Adults
|
|
670
|
|
|
‡a
Author's Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries
|
|
670
|
|
|
‡a
Author's Who should be prioritised for COVID-19 vaccination?
|
|
909
|
|
|
‡a
(orcid) 0000000230779639
‡9
1
|
|
919
|
|
|
‡a
effectof10valentpneumococcalconjugatevaccineintroductiononpneumoniahospitaladmissionsinfijiatimeseriesanalysis
‡A
Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis
‡9
1
|
|
919
|
|
|
‡a
effectof10valentpneumococcalconjugatevaccineintroductiononpneumococcalcarriageinfijiresultsfrom4annualcrosssectionalcarriagesurveys
‡A
Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
‡9
1
|
|
919
|
|
|
‡a
effectofpneumococcalvaccinationonnasopharyngealcarriageofstreptococcuspneumoniaehaemophilusinfluenzaemoraxellacatarrhalisandstaphylococcusaureusinfijianchildren
‡A
Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children
‡9
1
|
|
919
|
|
|
‡a
discoveryofastreptococcuspneumoniaeserotype33fcapsularpolysaccharidelocusthatlackswcjeandcontainsawcyopseudogene
‡A
Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene
‡9
1
|
|
919
|
|
|
‡a
determiningthepneumococcalconjugatevaccinecoveragerequiredforindirectprotectionagainstvaccinetypepneumococcalcarriageinlowandmiddleincomecountriesaprotocolforaprospectiveobservationalstudy
‡A
Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study.
‡9
1
|
|
919
|
|
|
‡a
associationsbetweenethnicitysocialcontactandpneumococcalcarriage3yearspostpcv10infiji
‡A
Associations between ethnicity, social contact, and pneumococcal carriage three years post-PCV10 in Fiji
‡9
1
|
|
919
|
|
|
‡a
causespecificmorbidityandmortalityandreferralpatternsofallneonatesadmittedtoatertiaryreferralhospitalinthenorthernprovincesofvietnamovera1yearperiod
‡A
The cause-specific morbidity and mortality, and referral patterns of all neonates admitted to a tertiary referral hospital in the northern provinces of Vietnam over a one year period.
‡9
1
|
|
919
|
|
|
‡a
challengesofusingoropharyngealsamplestomeasurepneumococcalcarriageinadults
‡A
The Challenges of Using Oropharyngeal Samples To Measure Pneumococcal Carriage in Adults
‡9
1
|
|
919
|
|
|
‡a
sustainedantibodyresponses6yearsfollowing12or3dosesofquadrivalenthumanpapillomavirushpvvaccineinadolescentfijiangirlsandsubsequentresponsestoasingledoseofbivalenthpvvaccineaprospectivecohortstudy
‡A
Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study
‡9
1
|
|
919
|
|
|
‡a
usingpneumococcalcarriagestudiestomonitorvaccineimpactinlowandmiddleincomecountries
‡A
Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries
‡9
1
|
|
919
|
|
|
‡a
reducedil17asecretionisassociatedwithhighlevelsofpneumococcalnasopharyngealcarriageinfijianchildren
‡A
Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children
‡9
1
|
|
919
|
|
|
‡a
whoshouldbeprioritisedforcovid19vaccination
‡A
Who should be prioritised for COVID-19 vaccination?
‡9
1
|
|
919
|
|
|
‡a
reduceddosehumanpapillomavirusvaccinationanupdateofthecurrentstateoftheart
‡A
Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art
‡9
1
|
|
919
|
|
|
‡a
realtimeqpcrimprovesmeningitispathogendetectionininvasivebacterialvaccinepreventablediseasesurveillanceinfiji
‡A
Real-time qPCR improves meningitis pathogen detection in invasive bacterial-vaccine preventable disease surveillance in Fiji
‡9
1
|
|
919
|
|
|
‡a
pneumococcalcarriageinvaccineeligiblechildrenandunvaccinatedinfantsinlaopdr2yearsfollowingtheintroductionofthe13valentpneumococcalconjugatevaccine
‡A
Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine
‡9
1
|
|
919
|
|
|
‡a
nolongtermevidenceofhyporesponsivenessafteruseofpneumococcalconjugatevaccineinchildrenpreviouslyimmunizedwithpneumococcalpolysaccharidevaccine
‡A
No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine
‡9
1
|
|
919
|
|
|
‡a
longtermimpactofpneumococcalpolysaccharidevaccinationonnasopharyngealcarriageinchildrenpreviouslyvaccinatedwithvariouspneumococcalconjugatevaccineregimes
‡A
Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes
‡9
1
|
|
919
|
|
|
‡a
factorsassociatedwithpneumococcalcarriageanddensityininfantsandyoungchildreninlaospdr
‡A
Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR
‡9
1
|
|
919
|
|
|
‡a
factorsassociatedwithpneumococcalcarriageanddensityinchildrenandadultsinfijiusing4crosssectionalsurveys
‡A
Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
BNF|14588768
|
|
996
|
|
|
‡2
DBC|87097992020193
|
|
996
|
|
|
‡2
J9U|987007457228705171
|
|
996
|
|
|
‡2
DNB|1156637112
|
|
996
|
|
|
‡2
LC|nr2001036632
|
|
996
|
|
|
‡2
ISNI|0000000116318396
|
|
996
|
|
|
‡2
BIBSYS|15013877
|
|
996
|
|
|
‡2
BIBSYS|9059734
|
|
996
|
|
|
‡2
RERO|A009451982
|
|
996
|
|
|
‡2
LC|no2014025972
|
|
996
|
|
|
‡2
CAOONL|ncf11396604
|
|
996
|
|
|
‡2
SUDOC|230318967
|
|
996
|
|
|
‡2
SUDOC|264158180
|
|
996
|
|
|
‡2
B2Q|0000082975
|
|
996
|
|
|
‡2
ISNI|0000000451364189
|
|
996
|
|
|
‡2
BIBSYS|6077209
|
|
996
|
|
|
‡2
LC|no 99053356
|
|
996
|
|
|
‡2
SUDOC|06903558X
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
